Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does magnesium therapy early in acute MI reduce mortality?

John Phillips1, Alex Krist

  • 1Virginia Commonwealth University, Fairfax Family Practice Residency, VA, USA.

The Journal of Family Practice
|March 7, 2003
PubMed
Summary

Early intravenous magnesium does not reduce short-term mortality in high-risk acute myocardial infarction (MI) patients. Magnesium is only recommended for patients with low magnesium levels or specific arrhythmias.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

The New England journal of medicine·2026
Same author

Efgartigimod as a treatment for adults with primary immune thrombocytopenia: a plain language summary of the ADVANCE IV study.

Therapeutic advances in hematology·2026
Same author

Whole Person Health Care: A Way Forward.

American journal of lifestyle medicine·2026
Same author

Diagnostic Accuracy of a Novel Point of Care High-Sensitivity Troponin Assay in the Prehospital Environment.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2026
Same author

The Emerging Role of B Cells and Tertiary Lymphoid Structures in Bladder Cancer.

Current urology reports·2025
Same author

Map of spiking activity underlying change detection in the mouse visual system.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute myocardial infarction (MI) is a leading cause of mortality.
  • Magnesium is an essential electrolyte involved in cardiac function.
  • Previous studies have suggested potential benefits of magnesium in MI management.

Purpose of the Study:

  • To evaluate the efficacy of early intravenous magnesium administration in reducing short-term mortality in high-risk acute myocardial infarction patients.

Main Methods:

  • A clinical trial involving high-risk patients with acute myocardial infarction.
  • Early administration of intravenous magnesium was compared to placebo or standard care.
  • Short-term mortality was the primary endpoint.

Main Results:

Related Experiment Videos

  • Early intravenous magnesium administration did not significantly reduce short-term mortality in high-risk acute MI patients.
  • No significant benefit was observed in secondary endpoints related to cardiac events.
  • The findings suggest that routine magnesium use in this population is not beneficial.

Conclusions:

  • Early intravenous magnesium is not indicated for high-risk acute myocardial infarction patients without specific contraindications.
  • Magnesium repletion should be reserved for patients with documented hypomagnesemia or arrhythmias responsive to magnesium.
  • Further research may explore magnesium's role in specific subgroups or for different indications.